Morgan Stanley Maintains Overweight on Lam Research, Raises Price Target to $404

Benzinga Newsdesk www.benzinga.com Positive 72.5%

Neg 0% Neu 0% Pos 72.5%

Morgan Stanley analyst Shane Brett maintains Lam Research (NASDAQ:LRCX) with a Overweight and raises the price target from $331 to $404.